3,3',5,5'-Tetrakis(methoxymethyl)-[1,1'-biphenyl]-4,4'-diol, 97.0%, 1g

TERT-BUTYL 3-(1-(((BENZYLOXY)CARBONYL)AMINO)-2-METHOXY-2-OXOETHYL)AZETIDINE-1-CARBOXYLATE, 95.0%, 10g

N-Carbobenzyloxy-D-serine-beta-lactone, 95.0%, 1g

5-Bromo-m-xylene>98.0%(GC)5g

Diethyl [(4-tert-butylphenyl)methyl]phosphonate, 1g

Phenyl hydrogen ((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphonate, 97%, 5g

Bis(isothiocyanato)bis(2,2'-bipyridyl-4,4'-dicarboxylato)ruthenium(II)>85.0%(HPLC)200mg

(S)-2,5-Diaminopentanoic acid compound with 2-oxopentanedioic acid (1:1), 95.0%, 250g

2H-1,4-Benzodiazepin-2-one, 3-amino-1,3-dihydro-5-phenyl-, (3S)-, 98%, 100mg

N-FMOC-N'-BOC-N'-ISOPROPYL-L-LYSINE, 95%, 5g

Ethyl 5-chloropentanoate, 97%, 25g

Sodium sulphate decahydrate, min. 99%, pa, ACS, 500 g, plastic packaging.

4-AMINOINDOLIN-2-ONE, 95.0%, 1g